Esco Lifesciences Group Acquires Evidence Solution

Entrust Acquires Evidos

June 8, 2022

Cloud & SaaS

Entrust has acquired Netherlands-based Evidos, a cloud-based electronic signature and identity verification provider. The acquisition brings Evidos' ~35 employees, European customer base and e-signature technology into Entrust to expand its digital signing and ID verification capabilities globally; terms were not disclosed.

EQT, Silver Lake and Nestlé Expand Partnership with €3.5bn Investment in IVC Evidensia

February 9, 2021

Veterinary

IVC Evidensia has secured an aggregated new investment of €3.5 billion that values the company at an enterprise value of approximately €12.3 billion. The expanded partnership includes a substantial reinvestment by EQT Private Equity, a new minority investment from Silver Lake, and an increased minority stake from Nestlé Purina PetCare EMENA to support digitalisation and further growth across IVC's network of clinics.

ECI Software Solutions Acquires ES Tech Group

October 7, 2022

Cloud & SaaS

ECI Software Solutions has completed the acquisition of ES Tech Group, a U.K.-based B2B eCommerce software and services company. The deal expands ECI's cloud-based eCommerce portfolio and brings ES Tech's platform and growth-agency capabilities into ECI's suite to better serve SME manufacturers, distributors and wholesalers.

United BioSource (UBC) Acquires Evidinno Outcomes Research

January 5, 2026

Healthcare Services

United BioSource LLC (UBC) has acquired Vancouver-based Evidinno Outcomes Research Inc., adding real-world evidence (RWE), epidemiology, evidence synthesis and HEOR capabilities to UBC's evidence-generation platform. Evidinno will operate as a wholly owned subsidiary of UBC; Fairmount Partners served as exclusive financial advisor to Evidinno.

Buenavista Equity Partners (via Evidenze) Acquires Chrestos Concept GmbH & Co. KG

November 22, 2024

Healthcare Services

Buenavista Equity Partners has acquired German CRO Chrestos Concept GmbH & Co. KG through its healthcare platform Evidenze Group Europe. The add-on expands Evidenze's capabilities in clinical trial design, biostatistics and data science and strengthens its presence in Germany as part of a buy-and-build strategy.

Saint-Gobain Life Sciences Acquires Equflow B.V.

September 2, 2021

Medical Devices

Saint-Gobain Life Sciences has acquired Equflow B.V., a Netherlands-based designer and manufacturer of flowmeters and sensors serving the single-use bioprocessing market. The acquisition expands Saint-Gobain's Bio-Process Solutions product capabilities and single-use fluid management offerings.